The Clinical Impact of Mitral Gradient Post Transcatheter Edge‐To‐Edge Repair: A Systematic Review and Meta‐Analysis
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31321 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Mohamad S Alabdaljabar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Cardiac Catheterization, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Mitral transcatheter edge‐to‐edge repair (TEER) is a minimally invasive therapy for severe mitral regurgitation (MR) in patients with high surgical risk. TEER results in a tissue bridge that decreases mitral valve area, potentially leading to elevated mean gradient. The clinical impact of elevated gradient on outcomes is unclear.
Methods
This systematic review and meta‐analysis was based on a comprehensive search of five databases. We included studies that evaluated post mitral TEER gradient on one of the following outcomes: all‐cause mortality, combined endpoints, symptoms, hospitalizations, and mitral valve re‐intervention. Meta‐analysis was conducted using the random‐effects model.
Results
Out of 6458 citations, 17 studies were included (2017−2024) reporting on 7748 patients. There was significant heterogeneity between studies related to the cutoff used to define elevated gradient, etiology of MR, and outcomes. Elevated mitral gradient post TEER (4, 4.5, 5 mmHg) was associated with worse combined endpoint (HR = 1.35, 95% CI 1.07−1.71; I 2 64%), but not all‐cause mortality (HR = 1.25, 95% CI 0.97−1.59; I 2 45%) or risk of hospitalization. For the combined endpoint, this association was mainly significant in patients who had mitral gradient assessed using discharge echocardiogram (HR = 1.39, 95% CI 1.07−1.81; I 2 62%) for all patients and for those with degenerative MR.
Conclusion
Despite the heterogeneity between studies, the current analysis suggests that patients with elevated mitral gradient post TEER are at risk of worse clinical outcomes, particularly in patients who had mitral gradient assessed using discharge transthoracic echocardiogram.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
- Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Alyaman Almiro, Mackram F Eleid
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Alabdaljabar, M. S., Almiro, A., Khan, J., Gerberi, D. J., Murad, M. H., Thaden, J. J., Rihal, C. S., & Eleid, M. F. (2025). The Clinical Impact of Mitral Gradient Post Transcatheter Edge‐To‐Edge Repair: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31321
Vancouver
Alabdaljabar MS, Almiro A, Khan J, Gerberi DJ, Murad MH, Thaden JJ, et al. The Clinical Impact of Mitral Gradient Post Transcatheter Edge‐To‐Edge Repair: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31321
BibTeX
@article{Alabdaljabar2025,
author = {Alabdaljabar, Mohamad S and Almiro, Alyaman and Khan, Jibran and Gerberi, Dana J and Murad, M Hassan and Thaden, Jeremy J and Rihal, Charanjit S and Eleid, Mackram F},
title = {The Clinical Impact of Mitral Gradient Post Transcatheter Edge‐To‐Edge Repair: A Systematic Review and Meta‐Analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31321}
}
EUVIMED